OYSTER POINT PHARMA INC (OYST)
US69242L1061 - Common Stock
OYSTER POINT PHARMA INC
NASDAQ:OYST (12/30/2022, 7:00:02 PM)
After market: 11.17 0 (0%)11.17
+0.02 (+0.18%)
Company Profile
Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. The company is headquartered in Princeton, New Jersey and currently employs 303 full-time employees. The company went IPO on 2019-10-31. The firm is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. The firm's lead product candidate is TYRVAYA Nasal Spray, a nicotinic acetylcholine receptor (nAChR) agonist for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray’s is a mechanism of action, which is designed to re-establish tear film homeostasis by stimulating the trigeminal nerve, activating the trigeminal parasympathetic pathway (TPP) and stimulating the glands and cells responsible for natural tear film production. The company is sprayed into the anterior portion of the nasal cavity and stimulates nAChRs located on the chemosensory endings of the trigeminal nerve resulting in cholinergic neurotransmission.
Company Info
OYSTER POINT PHARMA INC
202 Carnegie Center, Suite 106
Princeton NEW JERSEY 08540
P: 16093829032.0
CEO: Jeffrey Nau
Employees: 303
Website: https://oysterpointrx.com/
OYST News
a year ago - InvestorPlaceThe 7 Best Crypto and Stocks to Buy as Christmas Gifts This YearThese stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season.
a year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, ELVT, LBC, OYST/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
a year ago - InvestorPlaceThe 7 Hottest Healthcare Stocks to Own for 2023 and BeyondThese seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.
a year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, SAL, LBC, OYST/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
a year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGFS, ATCO, LBC, OYST/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
a year ago - Kahn Swick & Foti, LLCOYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYSTOYST Twits
Here you can normally see the latest stock twits on OYST, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
